A focus group study reviewed provider practices to learn more about patient management and explore the potential to follow up with clinicians on important takeaways.
This technology is effective in cases that are difficult to diagnose.
Salmonella becomes more dangerous as antimicrobial resistance grows. Read about its most common manifestations.
Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.
"This case gives uncomfortable insight into a gap in early detection of infections in immunocompromised, high-risk patient populations. "
This agent is likely best utilized as part of a combination when treating this bacterium but data regarding appropriate combinations are scarce.
A patient presented with a history of uncontrolled HIV and a history of polysubstance use.
Emergency departments (EDs) are an important entry point into the health care system and have been identified as a location with opportunity for increased HIV diagnosis and management.
Despite hepatitis C (HCV) incidence rates increasing, adequate screening for the virus continues to be a pressing challenge for public health officials.
There has been an emergence of extracorporeal membrane oxygenation-associated infections. Here is a review of how to define them and clinical management of this heterogeneous syndrome.
Escalating usage and more drug choices are putting more people at risk.
Carol Pandak, EdD, director of PolioPlus, Rotary International, discusses the significance of this day and efforts that continue around the world to work towards eradication of this disease.
With antimicrobial drug shortages expected to continue globally, developing mitigation strategies is essential to prevent complications, including antimicrobial resistance.
As the cohort of people living with HIV in the US ages, HIV care programs must rapidly adapt to the changing needs of older adults with HIV.
Nigel McCracken, PhD, presents a diagnostic test to identify early T cell dysfunction in syndromes like Long COVID and ME/CFS, aiming to improve treatment strategies before symptoms escalate.
This market has seen a flurry of activity, as shown by a review of the latest agents.
In the second part of their interview, Debika Bhattacharya, MD MSc, and Su H. Wang, MD, MPH, FACP, continue the conversation around the difficulties of getting people into care, and what the new hepatitis B guidelines hope to improve in this area.
Jeffrey Freiberg, MD, PhD review of the SABATO trial on oral antibiotics for S aureus bacteremia and a comparison of mupirocin and iodine treatments for MRSA decolonization.
Although the pandemic halted many medical mission assignments, these opportunities and others are becoming available to help those geographic areas with acute needs.
For patients undergoing surgery, looking at the potential benefits of this antimicrobial for prophylaxis.
During these uncertain times, RAIN President and CEO Chelsea Gulden talks about the importance of taking a grassroots approach to HIV advocacy to work with young people in the local communities who are either dealing with the virus or are susceptible to it.
New meta-analysis at the 2025 vaccinology conference highlights the efficacy of maternal RSV vaccines, with calls for enhanced monitoring following safety issues with one candidate
Stacy Lindborg, PhD, highlights the vaccine’s immune response, safety, and global distribution potential.
Syra Madad, DHSC, MSc, MCP, CHEP, outlines early surveillance systems and diagnostic innovations for enhancing pandemic management and response.
This systematic review focuses on breakthrough invasive fungal infections (bIFIs) in patients with high-risk hematological cancers, like acute leukemia, or those who have undergone stem cell transplants. Despite prophylactic antifungal treatments (usually with voriconazole or posaconazole), bIFIs remain challenging due to their complexity and high mortality rates.
Investigators evaluated strategies to simplify the vaccination process to yield higher rates of adult immunization, similar to that of the COVID-19 pandemic.
Epidemiologic and clinical lessons for the uninitiated.
In this case study, clinicians review a challenging case.
Rifaquizinone is a dual-pharmacophore antibiotic combining rifamycin and a fluoroquinolone-like compound, showing strong bactericidal activity against resistant Staphylococcus aureus strains and biofilms, with promising results for treating prosthetic joint infections (PJI) but limited oral bioavailability.
Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?